Upexi (NASDAQ:UPXI) Shares Up 26.7% - Time to Buy?

Upexi, Inc. (NASDAQ:UPXI - Get Free Report) shares were up 26.7% on Tuesday . The stock traded as high as $4.20 and last traded at $4.13. Approximately 9,494,470 shares changed hands during trading, an increase of 768% from the average daily volume of 1,093,281 shares. The stock had previously closed at $3.26.

Wall Street Analysts Forecast Growth

A number of equities analysts have commented on the company. Cantor Fitzgerald upgraded Upexi from a "neutral" rating to an "overweight" rating and set a $16.00 target price for the company in a research note on Monday, June 16th. Wall Street Zen upgraded Upexi to a "hold" rating in a research report on Friday, May 30th.

Upexi Price Performance

The firm's fifty day moving average price is $8.96 and its 200-day moving average price is $5.72. The company has a current ratio of 0.37, a quick ratio of 0.24 and a debt-to-equity ratio of 0.31.

Upexi (NASDAQ:UPXI - Get Free Report) last issued its quarterly earnings data on Friday, May 16th. The company reported ($2.87) earnings per share for the quarter. Upexi had a negative net margin of 135.86% and a negative return on equity of 535.19%. The firm had revenue of $3.16 million during the quarter.

Insider Activity

In other Upexi news, CFO Andrew James Norstrud purchased 43,860 shares of Upexi stock in a transaction on Thursday, April 17th. The stock was bought at an average price of $2.28 per share, for a total transaction of $100,000.80. Following the transaction, the chief financial officer owned 59,138 shares of the company's stock, valued at $134,834.64. The trade was a 287.08% increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, CEO Allan Marshall purchased 657,895 shares of the firm's stock in a transaction dated Thursday, April 17th. The stock was acquired at an average cost of $2.28 per share, with a total value of $1,500,000.60. Following the purchase, the chief executive officer owned 809,318 shares of the company's stock, valued at approximately $1,845,245.04. This represents a 434.47% increase in their position. The disclosure for this purchase can be found here. Over the last 90 days, insiders have acquired 942,984 shares of company stock valued at $2,150,004. Insiders own 31.60% of the company's stock.

Institutional Investors Weigh In On Upexi

An institutional investor recently bought a new position in Upexi stock. Bank of Montreal Can purchased a new position in shares of Upexi, Inc. (NASDAQ:UPXI - Free Report) during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund purchased 10,008 shares of the company's stock, valued at approximately $36,000. Bank of Montreal Can owned approximately 0.81% of Upexi at the end of the most recent quarter. 5.68% of the stock is currently owned by institutional investors.

About Upexi

Upexi, Inc manufactures and sells various branded products in the health, wellness, pet, beauty, and other markets. The company was formerly known as Grove, Inc and changed its name to Upexi, Inc in August 2022. The company was incorporated in 2018 and is headquartered in Clearwater, Florida.